In this paper we extend the refined second-order Poincaré inequality in [2] from a one-dimensional to a multi-dimensional setting. Its proof is based on a multivariate version of the Malliavin-Stein method for normal approximation on Poisson spaces. We also present an application to partial sums of vector-valued functionals of heavytailed moving averages. The extension we develop is not only in the co-domain of the functional, but also in its domain. Such a set-up has previously not been explored in the framework of stable moving average processes. It can potentially capture probabilistic properties which cannot be described solely by the one-dimensional marginals, but instead require the joint distribution.
In this article we present a parametric estimation method for certain multiparameter heavy-tailed Lévy-driven moving averages. The theory relies on recent multivariate central limit theorems obtained via Malliavin calculus on Poisson spaces. Our minimal contrast approach is related to previous papers, which propose to use the marginal empirical characteristic function to estimate the one-dimensional parameter of the kernel function and the stability index of the driving Lévy motion. We extend their work to allow for a multiparametric framework that in particular includes the important examples of the linear fractional stable motion, the stable Ornstein-Uhlenbeck process, certain CARMA(2, 1) models, and Ornstein-Uhlenbeck processes with a periodic component among other models. We present both the consistency and the associated central limit theorem of the minimal contrast estimator. Furthermore, we demonstrate numerical analysis to uncover the finite sample performance of our method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.